Back to search results
Terminated

Mild Alzheimer's, Mild Cognitive Impairment

A Study of LY2599666 in Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

ALCA | {{ defaultRegistry.registryAnchorText }} NCT02614131 {{ currentLocaleObject.registryAnchorText }}

Print Icon
See If You Pre-Qualify

Study Purpose

The main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY2599666 in different groups of people - those who have mild cognitive impairment due to Alzheimer's Disease (AD) and those with mild-to-moderate AD.

Terminated Study

This trial stopped recruiting or enrolling participants prematurely and will not start again. We are no longer examining or treating participants. The trial may have been stopped for many reasons. You may contact Lilly for further information.

Time Commitment

Your participation could last up to 22 weeks and include 34 visits to the study center.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study

Gender

Male Female

Age

20+ years

  • Part B and C Participant must be at least 50 years old

  • Part B and C Participant must have someone (caregiver or informant/partner) who provides a separate written informed consent to participate

  • Part B and C Participant must be able and willing to have an MRI (magnetic resonance imaging)

Study Summary Tool Tip Icon

Enrollment Goal Tool Tip Icon

130

Study Dates Tool Tip Icon

December 2015 - December 2016

Phase Tool Tip Icon

1

Condition(s) Tool Tip Icon

Mild Alzheimer's Disease, Mild Cognitive Impairment

Study Intervention(s) Tool Tip Icon

LY2599666, Solanezumab, Placebo

Could I Receive a Placebo? Tool Tip Icon

Yes

Discuss with the study center for details

Where This Study Took Place Tool Tip Icon

Where This Study Took Place Tool Tip Icon

Invalid Postal Code.
Please re-enter postal code.
Sort locations

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
,

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.